Skip to main content
Premium Trial:

Request an Annual Quote

Zygogen Provides Curis with Transgenic Zebrafish Technology

NEW YORK, Feb 21 - Zygogen of Atlanta will provide Curis with its
proprietary transgenic zebrafish technology for use in genomics-based drug
discovery, Zygogen said Wednesday.

Zebrafish are similar to knockout mice in that they can serve as model
organisms for finding genome-based drug targets, but they offer the
advantage of being faster to breed and less expensive.

Zygogen, founded in 1999, uses Z-Tag, a technology through which it can
design transgenic zebrafish with organs that are labeled and cell lineages
that are delineated.

"We are pleased to provide Curis with access to Zygogen's zebrafish
technology," said Nina Sawczuk, Zygogen's  CEO. "We are confident that our
technology will accelerate their drug screening programs."

This agreement follows closely after the Sanger Center's announcement it
would begin sequencing the full genome of the zebrafish. Other companies,
such as Artemis pharmaceuticals of Tubingen, Germany, are also seeking to
commercialize zebrafish technology to identify potential gene-based drug
targets.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.